Quantcast

Latest Coronary stent Stories

2013-09-24 23:40:13

Barnes-Jewish Hospital is the only hospital in the region implanting a new drug-eluting stent to treat symptomatic blockages of leg arteries caused by peripheral artery disease. St. Louis (PRWEB) September 24, 2013 Although drug-coated stents have been commonly used in coronary procedures, the technology is new to the treatment of peripheral artery disease (PAD). Patrick Geraghty, MD, FACS, Washington University vascular surgeon at Barnes-Jewish Hospital, is the first in the regional area...

2013-09-19 23:21:39

Reportbuyer.com just published a new market research report: MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts. London (PRWEB) September 19, 2013 Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon...

2013-09-17 23:01:33

ABSORB III nationwide clinical trial evaluating the efficiency and safety of absorb drug-eluting Bioresorbable Vascular Scaffolds (Absorb BVS) for coronary artery disease patients. New York, NY (PRWEB) September 17, 2013 The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery blockages. The randomized trial aims to compare...

2013-09-11 23:04:03

Transparency Market Research published new "Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 – 2016)" market research report to its report store. Browse the report with TOC, visit http://www.transparencymarketresearch.com/coronary-stents-market.html. Albany, New York, USA (PRWEB) September 11, 2013 According to Transparency Market Research “Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 – 2016)” Global...

2013-09-02 23:00:52

Worldwide study of more than 11,000 female patients provides evidence that stents can be safe and efficient in women who are traditionally underrepresented in clinical trials. New York, NY (PRWEB) September 02, 2013 Cardiac stents to open blocked heart arteries and reduce chest pain have been used for decades. However, cardiologists have never been certain that women benefitted from their use because clinical trials testing stents only included, at most, 25 percent women, making the...

2013-08-19 10:14:30

Older heart patients present unique challenges for determining the optimal dosages of medications, so a new study from researchers at Duke Medicine offers some rare clarity about the use of drugs that are used to treat patients with heart attacks. For certain heart patients older than age 75, a half-dose of the anti-platelet drug prasugrel works about as well as the typical dosage of clopidogrel, according to a team led by the Duke Clinical Research Institute that looked at a sub-study of...

2013-08-09 23:21:22

“Research on China Coronary Stent Industry, 2013-2017” and “Global Coronary Stents - Market Growth Analysis 2009-2015” are market research reports available at ReportsnReports.com store. Dallas, TX (PRWEB) August 09, 2013 The recent research report “Research on China Coronary Stent Industry, 2013-2017” takes a view that, from the aspects of market scale, the annual growth rate of stent system will remain 8% globally on the whole. At present, cardiac Interventional surgeries in...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.